![Stefan Luzi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stefan Luzi
Directeur/Bestuurslid bij Amphista Therapeutics Ltd.
Actieve functies van Stefan Luzi
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Gilde Healthcare Partners BV
![]() Gilde Healthcare Partners BV Investment ManagersFinance Gilde Healthcare Partners BV is a Private Equity/Venture Capital firm, a subsidiary of Gilde Healthcare Holding BV founded in 1999 by Pieter van der Meer and Edwin William de Graaf. Gilde Healthcare Partners BV is headquartered in Utrecht with additional office in Cambridge. | Private Equity Investor | 01-08-2017 | - |
Private Equity Analist | 01-04-2015 | 01-08-2017 | |
Amphista Therapeutics Ltd.
![]() Amphista Therapeutics Ltd. BiotechnologyHealth Technology Amphista Therapeutics Ltd. is a biopharmaceutical company based in Biocity Glasgow, UK. The British company is focused on creating first-in-class therapeutics that selectively and efficiently degrade and remove disease-causing proteins using targeted protein degradation (TPD). The company's pipeline of novel small molecules is focused on challenging diseases, including cancer. Amphista is a spin-out of Professor Alessio Ciulli's labs at the University of Dundee and is funded by leading life science investors, including Advent Life Sciences, the European Investment Fund, the Scottish Investment Bank, and Biomotiv. The CEO of the company is Nicola Thompson. | Directeur/Bestuurslid | - | - |
Loopbaan van Stefan Luzi
Eerdere bekende functies van Stefan Luzi
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LAVA THERAPEUTICS N.V. | Directeur/Bestuurslid | 01-01-2018 | 09-03-2023 |
Draupnir Bio ApS
![]() Draupnir Bio ApS Pharmaceuticals: MajorHealth Technology Draupnir Bio ApS engages in the manufacture and distribution of biotechnological and pharmaceutical products. It also provides medical research services. The company was founded on April 4, 2017 and is headquartered in Risskov, Denmark. | Directeur/Bestuurslid | - | - |
Opleiding van Stefan Luzi
Swiss Federal Institute of Technology | Graduate Degree |
University of Cambridge | Doctorate Degree |
Statistieken
Internationaal
Nederland | 3 |
Verenigd Koninkrijk | 3 |
Zwitserland | 2 |
Operationeel
Director/Board Member | 3 |
Graduate Degree | 2 |
Private Equity Analyst | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
LAVA THERAPEUTICS N.V. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Gilde Healthcare Partners BV
![]() Gilde Healthcare Partners BV Investment ManagersFinance Gilde Healthcare Partners BV is a Private Equity/Venture Capital firm, a subsidiary of Gilde Healthcare Holding BV founded in 1999 by Pieter van der Meer and Edwin William de Graaf. Gilde Healthcare Partners BV is headquartered in Utrecht with additional office in Cambridge. | Finance |
Draupnir Bio ApS
![]() Draupnir Bio ApS Pharmaceuticals: MajorHealth Technology Draupnir Bio ApS engages in the manufacture and distribution of biotechnological and pharmaceutical products. It also provides medical research services. The company was founded on April 4, 2017 and is headquartered in Risskov, Denmark. | Health Technology |
Amphista Therapeutics Ltd.
![]() Amphista Therapeutics Ltd. BiotechnologyHealth Technology Amphista Therapeutics Ltd. is a biopharmaceutical company based in Biocity Glasgow, UK. The British company is focused on creating first-in-class therapeutics that selectively and efficiently degrade and remove disease-causing proteins using targeted protein degradation (TPD). The company's pipeline of novel small molecules is focused on challenging diseases, including cancer. Amphista is a spin-out of Professor Alessio Ciulli's labs at the University of Dundee and is funded by leading life science investors, including Advent Life Sciences, the European Investment Fund, the Scottish Investment Bank, and Biomotiv. The CEO of the company is Nicola Thompson. | Health Technology |
- Beurs
- Insiders
- Stefan Luzi
- Ervaring